Effects of a Novel Anticoagulant Compound (TV7130) in an Ovine Model of Septic Shock
Fuhong Su(Université Libre de Bruxelles), Jean‐Louis Vincent(Université Libre de Bruxelles), Orit Cohen‐Barak(Teva Pharmaceuticals (Israel)), Hong-chuan Huang, Aric Orbach(Teva Pharmaceuticals (Israel)), David Simuen, Xinrong He(Sun Yat-sen University), Jingwei Xie(Université Libre de Bruxelles), Michaël Piagnerelli
Cited by 6
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k